| Literature DB >> 32895481 |
Shynggys Sergazy1, Zarina Shulgau2, Galina Fedotovskikh3, Laura Chulenbayeva1, Ayaulym Nurgozhina1, Madiyar Nurgaziyev1, Elena Krivyh4, Yevgeny Kamyshanskiy5, Almagul Kushugulova1, Alexander Gulyayev1, Mohamad Aljofan6.
Abstract
Doxorubicin is a chemotherapeutic agent known to cause cardiotoxicity that is thought to be associated with oxidative stress. The aim of the current study is to investigate the role of grape polyphenols' antioxidant property as cardioprotective against doxorubicin-induced cardiotoxicity. Adult Wistar rats weighing 200 ± 20 g were divided into 3 different groups: a doxorubicin group that received a single intraperitoneal administration of doxorubicin (8.0 mg/kg body weight), an experimental group that received doxorubicin and grape polyphenol concentrate (25 mg/kg) via intragastric route, and the third group was a negative control group that received water only. On day 8, blood samples and tissues were harvested for analyses. The results indicated that grape polyphenol concentrate was able to reduce the signs of cardiotoxicity of doxorubicin through the reduction of aspartate aminotransferase activation, increasing the plasma antioxidant levels and decreasing the level of free radicals. The results also showed that grape polyphenol concentrate was able to reverse doxorubicin-induced microscopic myocardial damage. The myocardial protective effect of grape polyphenol might likely be due to the increase in the level and activity of the antioxidant enzymes, superoxide dismutase, catalase, and glutathione peroxidase. In conclusion, grape polyphenol concentrate displayed cardioprotective effect and was able to reverse doxorubicin-induced-cardiomyopathy in experimental rats.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32895481 PMCID: PMC7477547 DOI: 10.1038/s41598-020-71827-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Antioxidant effects of grape polyphenol concentrate.
| The investigated parameters | Healthy animals, n = 6 | Doxorubicin, n = 7 | Experimental group, n = 9 |
|---|---|---|---|
| D-ROMs test, U Carr | 367.3 ± 67.2 | 554.3 ± 35.6* | 400.4 ± 14.8# |
| PAT test, U Cor | 2,992 ± 414 | 2,164 ± 172* | 2,667 ± 123*,# |
*P < 0.05 compare to the value in the group of healthy animals.
#P < 0.05 compare to the value in the group of control animals. Results presented are mean ± standard error of the mean.
The effect of the polyphenol concentrate on the activity of aspartate aminotransferase, (M ± m).
| The investigated parameters | Healthy animals, n = 6 | Doxirubicin, n = 7 | Experimental group, n = 9 |
|---|---|---|---|
| AST, nmol/(s·L) | 1,346 ± 82 | 1,897 ± 168* | 1,507 ± 130*,# |
*P < 0.05 compare to the value in the group of healthy animals.
#P < 0.05 compare to the value in the group of control animals. Results presented are mean ± standard error of the mean.
Troponin T (TnT).
| Sample | ng/ml |
|---|---|
| Healthy rats | 0.153 |
| Dox control rats | 1.071 |
| Dox + polyphenol rats | 0.808 |
The results of TnT levels from rat serum. The results are average of 3 independent experiments from 6 different animals.
Hematological effects of polyphenol concentrate, (M ± m).
| The investigated parameters | Healthy animals, n = 6 | Control, n = 7 | Experimental group, n = 9 |
|---|---|---|---|
| White blood cell count, 109/l | 15.9 ± 0.70 | 8.8 ± 0.26* | 8.9 ± 0.57* |
| Lymphocytes, 109/l | 10.9 ± 1.19 | 4.8 ± 0.36* | 4.9 ± 0.14* |
| Monocytes, 109/l | 1.2 ± 0.20 | 0.6 ± 0.07* | 0.6 ± 0.04* |
| Neutrophils, 109/l | 3.8 ± 0.50 | 3.5 ± 0.22 | 3.4 ± 0.41 |
| Lymphocytes, % | 67.3 | 54.0 | 54.3 |
| Monocytes, % | 7.8 | 6.3 | 7.4 |
| Neutrophils, % | 25.0 | 39.8 | 38.3 |
| Red blood cell count (RBC), 1012/L | 10.8 ± 0.82 | 10.9 ± 1.30 | 10.2 ± 0.94 |
| Hemoglobin (Hb), g/l | 203.7 ± 18.74 | 97.7 ± 11.05* | 180.0 ± 19.49# |
| Hematocrit, % | 60.7 | 54.6 | 58.9 |
| Mean cell volume (MCV), fl | 56.5 | 54.4 | 53.8 |
| Mean corpuscular hemoglobin (MCH), pg | 19.0 | 17.7 | 18.2 |
| Mean corpuscular hemoglobin concentration (MCHC), g/l | 335.7 | 305.6 | 330.4 |
| Red cell distribution width, % | 14.8 | 15.5 | 15.6 |
| Platelets, 109/l | 613.8 ± 39.67 | 426.3 ± 22.18* | 416.8 ± 67.20* |
| Thrombocrit (PCT), % | 0.4 | 0.3 | 0.3 |
| PLT, fl | 6.7 | 6.4 | 6.1 |
| PDW, % | 31.0 | 28.8 | 28.2 |
*P < 0.05 compare to the value in the group of healthy animals.
#P < 0.05 compare to the value in the group of control animals. Results presented are mean ± standard error of the mean.
Figure 1Percentage inhibition of SOD. The graph shows the inhibition of SOD activity as measured by the colorimetric absorbance method. The decrease in SOD activity is proportional to the amount of absorbance at 440 nm. Results presented are mean ± standard error of the mean of 5 independent experiments from 6 different animals per each treatment group. *Represents significance difference (α < 0.05).
Figure 2Catalase activity. The graph shows the measurement of hydrogen peroxide substrate remaining after catalase activity. The amount of the remaining substrate is conversely proportional to the antioxidant activity of catalase. Thus, high reading indicates low enzymatic activity. Results presented are mean ± standard error of the mean of 5 independent experiments from 6 different animals per each treatment group. *Represents significance difference (α < 0.05).
Measurement of glutathione level and activity.
| Samples | µmol/g protein | Activity (µmol/ml/min) |
|---|---|---|
| Healthy rats | 3.5 ± 0.3 | 0.09 |
| Dox control rats | 2.4 ± 0.7 | 0.05 |
| Dox + polyphenol rats | 3.3 ± 0.5 | 0.11 |
The table shows the approximate glutathione level and activity from 3 different animal groups.
Results presented are mean ± standard error of the mean of at least 3 independent experiments from 6 different animals.
Figure 3Electron Microscopy analyses. The above images are of rat myocardial tissues from doxorubicin treated animals (A–F) and grape polyphenol concentrate treated animals (G–L). Tissues from all the animals (6 per group) were analyzed and the images presented are from at least 3 different animals. Images were captured using MegaView G3 TEM-camera and RADIUS EM-Imaging Software. EMSIS GmbH, Muenster, Germany (www.emsis.eu).